Mark Heinen - Chief Financial Officer at Better Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
BTTX on Nasdaq
Industry
Services-Health Services
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Heinen since 7/4/2023

Holdings reported by Mark Heinen for Better Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 139,723 $23.7 K $0.17 Apr 5, 2023 Direct
Common Stock 2,281 $387 $0.17 Mar 1, 2023 By daughter
Stock Option (Right to Buy) 28,550 Mar 1, 2023 Direct Common Stock

Transactions reported by Mark Heinen for Better Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership